AwesomeCapital

Monday, October 31, 2022

Sweeping New Rules Will Curtail Student Loan Interest And Expand Loan Forgiveness Programs

›
  The Biden administration has released   final regulations   that will provide sweeping changes to the federal student loan system. The new...

Glucose monitoring device maker DexCom stock rallies more than 50% in October to pace the S&P 500

›
DexCom eased today but stayed  on track to be the S&P 500's best October performer with a month-to-date gain of 50.6%. The rally com...

Health-Care Stocks Rally to Best Month Since 2020 on Haven Demand

›
  Health care stocks posted their best monthly gain since April 2020 as investors seek shelter in a weakening economy. The S&P 500 Healt...

Colombia's Oil Industry In Jeopardy As Cocaine Production Soars To New Record

›
  By Matthew Smith of  OilPrice.com Leftwing Senator Gustavo Petro’s  electoral victory , which he was inaugurated as Colombia’s 34th presid...

FDA warns of tracheostomy tube shortage

›
  U.S. Food and Drug Administration (FDA) said on Monday there was a shortage of tracheostomy tubes, a surgical device that helps patients t...

Biohaven upped to Overweight from Neutral by Cantor

›
 Target $27 https://finviz.com/quote.ashx?t=BHVN&p=d

Monopar Announces Timeline of Upcoming Data Events for Validive, Camsirubicin, and MNPR-202

›
  Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics design...
‹
›
Home
View web version
Powered by Blogger.